Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor activity of R-116010 is due to inhibition of all-trans-retinoic acid metabolism

Aug. 2, 2002

Japanese, American and British scientists jointly describe new PI3K inhibitors

Aug. 1, 2002

New CDK inhibitors in early development at BMS

Aug. 1, 2002

Bristol-Myers Squibb researchers identify CDK-inhibitory semicarbazides

Aug. 1, 2002

Zonagen awarded SBIR grant for Progenta in breast cancer

Aug. 1, 2002

Xyotax enters phase III evaluation in ovarian cancer

July 31, 2002

DNA minor groove-binding antitumor agent with potential in refractory tumors

July 31, 2002

HDAC-inhibitory hydroxamates recently described in Roche patent

July 31, 2002

Liposomal TOP-53 may be associated with improved tolerance

July 31, 2002

SignalGene updates progress of SG-292

July 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026